학술논문
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
Document Type
Article
Author
Heudel, P.; Chabaud, S.; Perol, D.; Flechon, A.; Fayette, J.; Combemale, P.; Tredan, O.; Desseigne, F.; de la Fouchardiere, C.; Boyle, H.; Perol, M.; Bachelot, T.; Cassier, P.; Avrillon, V.; Terret, C.; Michallet, A.-S.; Neidhardt-Berard, E.-M.; Nicolas-Virelizier, E.; Dufresne, A.; Belhabri, A.; Brahmi, M.; Lebras, L.; Nicolini, F.; Sarabi, M.; Rey, P.; Bonneville-Levard, A.; Rochefort, P.; Provensal, A.-M.; Eberst, L.; Assaad, S.; Swalduz, A.; Saintigny, P.; Toussaint, P.; Guillermin, Y.; Castets, M.; Coutzac, C.; Meeus, P.; Dupré, A.; Durand, T.; Crochet, H.; Fervers, B.; Gomez, F.; Rivoire, M.; Gregoire, V.; Claude, L.; Chassagne-Clement, C.; Pilleul, F.; Mognetti, T.; Russias, B.; Soubirou, J.-L.; Lasset, C.; Chvetzoff, G.; Mehlen, P.; Beaupère, S.; Zrounba, P.; Ray-Coquard, I.; Blay, J.-Y.
Source
In ESMO Open February 2021 6(1)
Subject
Language
ISSN
2059-7029